Summary.-Hepatitis-B surface antigen (HBSAg) 
A CAUSAL relationship between chronic hepatitis-B virus (HBV) infection and primary hepatocellular cancer (PHC) is suggested by the frequency with which hepatitis-B surface antigen (HBsAg) (Sherlock et al., 1970; Prince et al., 1970; Vogel et al., 1970; Tong et al., 1971 ; Kew et al., 1974) and antibody against hepatitis-B core antigen (anti-HB,) (Maupas et al., 1975) are found in the serum of patients with this tumour. This association appears to be particularly strong in those areas of the world, such as the Far East and parts of Africa, where PHC occurs commonly (Prince et al., 1970; Vogel et al., 1970; Kew et al., 1974) . These areas also appear to have, in the general population, both a high carrier rate of HBV (Prince, 1971; Tong et al., 1971; Hersh et al., 1971; ) and a high incidence of acute virus-B hepatitis (Tong et al., 1971; Kew et al., 1974) . However, in countries in which PHC is rare, e.g. the United States, no obvious relationship between chronic HBS antigenaemia and the occurrence of this tumour has been demonstrated (Smith and Blumberg, 1970; Alpert and Isselbacher, 1971; Moertel, Gleich and Hull, 1970) , indicating that other factors must also be involved in the aetiology of PHC. Furthermore, the fact that yet other countries having a high carrier rate of, the virus and prevalence of chronic liver disease associated with HBV (Theodoropoulos, Archimandritis and Angelopoulos, 1975) have low or relatively low PHC rates suggests that the virus may only be oncogenic in combination with one or more of these other factors.
In this paper we report the prevalence of hepatitis-B surface antigen (HBsAg) and antibody (Anti-HB5) in southern African Bantu patients with PHC using the most sensitive laboratory techniques currently available.
MATERIALS AND METHODS
The study was based on 158 southern African Bantu patients with PHC. All but 2 of the patients were males, and the niiajority of these were mine labourers. (Gocke and Howe, 1970) and by solid phase radioimmunoassay (RIA) using Ausria 11-125 (Ling and Overby, 1970) . Specific antibody against HB,Ag (anti-HBs) was detected by passive haemagglutination (PH) (Vyas and Shulman, 1970) and RIA (Ginsburg et al., 1973) . The prevalence of HBsAg in the general Bantu as determined by CIEP was taken from the results of an earlier investigation (Ouchterlony, 1949) and/or CIEP ).
In those instances in which the level of the globulin was too low to be detected by these nmethods, RIA (Ruoslahti and Seppala, 1971) and 9% respectively. All the positive results with RIA, which were always confirmed with the neutralizing antibody technique (Prince et al., 1973) , had ct/min greater than 2 1 times the mean value established with the negative (anti-HB,) in 95% of our patients (Desmyter, Macnab and Kew, unpublished data). Even in those patients without demonstrable antigenaemia, it is possible that the virus may be present, either in non-neoplastic liver cells, or in cirrhotic liver cells (60% of our patients with PHC have underlying cirrhosis (Kew et al., 1974) ), or even in the neoplastic hepatocytes. The latter possibility is supported by our finding of HB,Ag in the supernatant fluid of an established PHC cell line in tissue culture (Macnab and Alexander, unpublished).
The overall prevalence of the HBV carrier state in the Bantu of southern Africa is 7 % but in some areas it is as high as 15.8% . Acute virus-B hepatitis is common in these people, constituting 54% of cases of acute viral hepatitis in children and 65% of such cases in adults . The prevalence of HBV in chronic active hepatitis and cirrhosis in the Bantu has not yet been ascertained. However, Hadziyannis and Merikas (1973) have shown that the frequency with which HBSAg is found in patients with PHC does not simply reflect a high incidence of HBsAg +ve cirrhosis in the same areas. If persistence of HBV does play a role in the aetiology of PHC, two possible mechanisms may be considered. Failure to clear the virus after an attack of acute hepatitis is known in some cases to lead to chronic active hepatitis and cirrhosis (Wright, McCollum and Klatskin, 1969; Sherlock et at., 1970) , and PHC not infrequently develops in livers which are cirrhotic (Berman, 1951; MacDonald, 1956; Lin, 1970) . HBsAg has been found in association with PHC in the absence of cirrhosis so that, alternatively, the virus may be directly oncogenic.
Although it is tempting to incriminate HBV in the aetiology of PHC in the Bantu, the possibility that its frequent presence is the consequence and not the cause of the tumour has not definitely been excluded. No obvious disturbance in immunological competence could be found in Ugandan patients with PHC (Primack, Vogel and Barker, 1973) , although a specific defect could not be excluded. We have not yet investigated the immunological status of our patients.
It has been suggested that either AFP is responsible for causing persistence of HBV (Ziegenfuss, 1973) , or that the virus triggers off AFP synthesis as part of its oncogenic potential (Alpert and Isselbacher, 1971) . Although our findings do not appear to support these hypotheses, the number of samples investigated in the patients with and without AFP (detectable by immunodiffusion and/or CIEP) were not sufficient to allow definite conclusions to be drawn.
The evidence that PHC has a multifactorial aetiology is convincing. An oncogenic role of the virus alone would not be in keeping with the observation that in some parts of the world there is no increase in prevalence of HB,Ag in patients with this tumour. Nor would it explain the epidemiological, clinical and experimental observations which suggest that an androgenic environrment favours the development of PHC (Johnson et al., 1972) , or the epidemiological data incriminating mycotoxins (British Medical Journal, 1975) or other toxins in the aetiology of PHC. However, it is possible that the virus is oncogenic in combination with one or more of these factors, and in the southern African Bantu, chronic virus-B hepatitis in association with aflatoxin ingestion may be the cause of this tumour.
